Dorothea Lentis

I have great experience in working with patients, within hospitals/medical settings and community care units, who in some cases may be experiencing high levels of stress, and exploring in depth issues of treatment. I am an experienced qualitative and quantitative researcher [MPhil & PhD]. For my BSc thesis in the US, I explored the effect of Interleukin-2 on Tumor Infiltrating Lymphocytes, derived from colon adenocarcinoma [collaboration with the National Institutes of Health]. This protocol is applied in cancer patients with solid tumors and represents a new approach in treatment through Adoptive Immunotherapy. I have great experience from the Pharmaceutical Industry, especially in the field of Dietary/Health Supplements. I have worked in major Companies, holding the position of Product and Training Manager. I have participated in the development and introduction to the Greek market of 200 formulations.

Recent Publications

• Lentis, D. (2023). Transition from institutional care to community care for residents of community care units in Greece: Construction of the notion of “asylum” in community care units. Dialogues in Clinical Neuroscience & Mental Health Dialogues. Volume 6, Issue 3, p. 89- 100. DOI: 10.26386/obrela. v6i3.271
• Lentis, D. (2023). Deinstitutionalisation of patients with Severe Mental Illness in Greece: Comparing and contrasting issues of treatment in mental health institutions vs community care units. Dialogues in Clinical Neuroscience & Mental Health Dialogues. Volume 6, Issue 4, p. 149- 158. DOI: 10.26386/obrela. v6i4.277